The Bulletin
The Times


.

Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

  • Written by PR Newswire
  • SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology.
  • With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, including those for pneumoniae and typhoid.
  • The company will accelerate its future growth strategies by exploring...
hacklink esim balkanzlibraryzlibrarySahabetuk casinos not on gamstopGamStopgrandpashabet girişviagra 100 mg fiyattaraftarium24taraftarium24taraftarium24